C12N 2820/005
Cell-cycle regulated
Official title: cell-cycle regulated
C12N2820/005 (Cell-cycle regulated) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 3
- Assignees
- 3
- Inventors
- 6
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Enabling cholesterol catabolism in mammalian cells lacking same10 Feb 2026US 12,545,918 B2University of South Alabama Foundation for Research and Commercialization
- Compostions and methods for enabling cholesterol catabolism in human cells28 Mar 2023US 11,612,619 B2National Institute of Health (NIH), U.S. Dept. Of Health and Human Services (DHHS), U.S. Government
- Bacterial strains for dna production14 Sep 2023US 2023/0287437 A1ModernaTX, Inc.
- Enabling cholesterol catabolism in human cells24 Aug 2023US 2023/0263829 A1University of South Alabama Foundation for Research and Commercialization
- Enabling cholesterol catabolism in human cells11 Jun 2020US 2020/0179452 A1University of South Alabama Foundation for Research and Commercialization
Most cited
By later US patents